Literature DB >> 17985012

Off-pump coronary artery bypass graft surgery after stent implantation in a patient with combined thrombophilic risk factors.

Zeynep Eyileten1, A Ruchan Akar, Mustafa Sirlak, Kemalettin Ucanok, Nejat Akar.   

Abstract

The case of coronary artery bypass graft surgery in a 51-year-old woman with a heterozygous form of factor V Leiden, prothrombin mutation G20210A and tumour necrosis factor-alpha -308 G-A associated with high lipoprotein(a) and homocysteinemia levels, as well as elevated factors VIIIc and IX, is presented. She suffered from recurrent episodes of venous thromboembolism and left anterior descending artery subtotal occlusion eight months after percutaneous transluminal coronary angioplasty and stent implantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17985012      PMCID: PMC2651937          DOI: 10.1016/s0828-282x(07)70878-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  Prothrombin gene 20210 G-A mutation in the Turkish population.

Authors:  N Akar; M Misirlioğlu; E Akar; F Avcu; A Yalçin; A Sözüöz
Journal:  Am J Hematol       Date:  1998-07       Impact factor: 10.047

2.  Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

Authors:  F R Rosendaal; D S Siscovick; S M Schwartz; R K Beverly; B M Psaty; W T Longstreth; T E Raghunathan; T D Koepsell; P H Reitsma
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

Review 3.  The controversy over homocysteine and cardiovascular risk.

Authors:  P M Ueland; H Refsum; S A Beresford; S E Vollset
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

4.  Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.

Authors:  C J Doggen; V M Cats; R M Bertina; F R Rosendaal
Journal:  Circulation       Date:  1998-03-24       Impact factor: 29.690

5.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.